Sophie Cromer, an 8-year-old from Alabama, has faced a challenging journey after being diagnosed with aplastic anemia at the ...

The 2023 AABB guidelines overall favor a restrictive transfusion strategy, recommending RBC transfusion for hemoglobin <7 ...

While B-ALL is the most common childhood cancer and one of the most treatable, some patients face grim outcomes after they ...

A subset of patients with myeloproliferative neoplasms (MPNs) -- clonal disorders of hematopoietic stem cells that include ...

In a recent study published in Nature Cancer, researchers explore treatment resistance and relapse in T-cell acute ...

Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel anti-CD19 chimeric antigen receptor (CAR) T cell therapy, obecabtagene ...

Feline Leukemia Virus is commonly referred to as FeLV. It is one of the most common infectious diseases in cats worldwide.

Other symptoms of anemia include weakness ... Calquence can be an effective treatment option for certain types of leukemia and lymphoma. But for some people, the drug can cause mild or serious ...

In aplastic anemia, regardless of the underlying etiology ... of the marrow tissue because of the rapid reversal of signs and symptoms indicating bone-marrow proliferation in a time relation ...

A nursery teacher was diagnosed with leukaemia after a pharmacist who battled the disease spotted her symptoms. Natalie Forrest, 40, had gone to collect antibiotics from her local chemist in ...

On November 15, 2024, the U.S. Food and Drug Administration (FDA) approved revumenib (Revuforj ®) for patients 1-year-old and older who have leukemia that has come back after treatment and whose ...